Emotional-distress-based Integrated Care Programme in Patients With Stable COPD
Emotional-distress-based Integrated Care Programme in Patients With Stable COPD - A Feasibility Study (EmoD-2)
University of Zurich
15 participants
Mar 16, 2026
INTERVENTIONAL
Conditions
Summary
The investigators have developed a new counselling service that focuses on the emotional distress experienced by people living with chronic obstructive pulmonary disease (\*COPD\*). The new programme is led by an advanced practice nursing (\*APN\*) team. Other professionals are involved in the programme, such as medical staff and physiotherapists. The new counselling service lasts three months. Patients will receive ten counselling sessions with a specialized nurse. The overall objective of the study is to assess the feasibility of the newly developed emotional-distress-based integrated care programme.
Eligibility
Inclusion Criteria3
- Patients with a confirmed diagnosis of COPD (GOLD 1-4) and existing lung function in the past 12 months
- Age ≥ 18
- Outpatient treatment on the pneumology clinic of the university hospital Zurich. Last consultation within the past 12 months
Exclusion Criteria6
- Significant changes in symptoms over the past 3 months that exceeded the everyday fluctuations and required intensification of treatment (moderate, severe exacerbations or pneumonia) and no COPD-related hospitalisation in the past 3 months
- Cognitive impairment (dementia, delirium)
- Unstable psychiatric situation, i.e., current psychiatric treatment due to personality disorder, schizophrenia, drug use, suicidal tendencies. No exclusion for nicotine and alcohol abuse, anxiety, and depression
- Not speaking or reading German
- Intervention via telephone or video call not possible
- Lung transplant (recipient or candidate)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Outpatients in a stable phase of chronic pulmonary disease (\*COPD\*) will be aligned to a nurse-led emotional-distress-based integrated care programme for three months.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07524023